Define aspermia
Reading File
Finding Sources
Reading File
Reading File
Reading File
Aspermia is the condition in which no fluid (semen) is discharged from the urethra during male orgasm — a "dry ejaculate." It is distinct from azoospermia (semen is present but contains no sperm).
The terms aspermia, dry ejaculate, and anejaculation are used interchangeably in this context.
Causes
Aspermia shares the same underlying causes as seminal hypovolemia (very low semen volume), including:
| Category | Examples |
|---|---|
| Anatomic | Ejaculatory duct obstruction or hypoplasia of the prostate/seminal vesicles (e.g., severe androgen deficiency, congenital bilateral absence of the vas deferens [CBAVD]) |
| Functional | Retrograde ejaculation (semen passes backward into the bladder) |
| Neurologic | Spinal cord injury, diabetes mellitus, multiple sclerosis |
| Pharmacologic | α-adrenergic blocking agents (e.g., tamsulosin), SSRIs, antipsychotics |
| Endocrine | Hypogonadism, hyperprolactinemia |
| Infectious/Inflammatory | Tuberculosis of the seminal vesicles, prostatitis, STIs causing ejaculatory duct obstruction |
| Iatrogenic | Radiation (e.g., treatment of seminoma), pelvic surgery |
Bilateral ejaculatory duct obstruction produces absent or near-absent semen because the seminal vesicles normally contribute ~80% of seminal volume. Their secretions are viscous, fructose-rich, and alkaline; when blocked, the result is aspermia or a tiny volume of low-pH, low-fructose, low-viscosity fluid.
Evaluation
When aspermia is found:
- Post-ejaculatory urinalysis — identifies retrograde ejaculation (sperm recovered in urine after orgasm).
- Transrectal ultrasound (TRUS) — evaluates for ejaculatory duct obstruction.
- Hormone panel — serum testosterone, FSH, prolactin to exclude endocrine causes.
- Medical/sexual history — rule out medications (SSRIs, α-blockers, antipsychotics) and neurologic disease.
Clinical Associations
- Cystic fibrosis: Men with CF commonly present with aspermia or azoospermia due to congenital bilateral absence of the vas deferens (CBAVD).
- Valganciclovir: May cause hypospermia or aspermia as a drug side effect.
- Male infertility workup: Aspermia is a recognized finding that prompts a full andrologic evaluation.
Sources: Campbell-Walsh-Wein Urology (9780323546423), Goldman-Cecil Medicine (9780323930345)
What is the reason behind using antigen tests in case of aspermia in seminal stains detection
Reading File
Finding Sources
Finding Sources
Searching the Web
antigen test seminal stain aspermia forensic identification PSA p30
This is a forensic medicine question with excellent sources. Here is the complete answer:
Why Antigen Tests Are Used for Seminal Stain Detection in Aspermia
The Core Problem
The traditional confirmatory test for seminal stains in forensic casework relies on microscopic identification of spermatozoa. However, this fails completely when the suspect has aspermia (no ejaculate fluid), azoospermia (semen with no sperm), or has undergone a vasectomy — because in all these conditions, no sperm cells are present in the ejaculate.
Yet, even in aspermia/azoospermia/vasectomy, the prostate gland continues to produce and secrete its own proteins independently of sperm production. This is the biological basis for antigen-based testing.
The Antigen Used: PSA / P30
Prostate-Specific Antigen (PSA), also called P30, is the primary forensic antigen marker used:
| Property | Detail |
|---|---|
| Chemical nature | 30,000-dalton glycoprotein (serine protease) |
| Source | Prostatic epithelium / prostatic gland |
| Function | Liquefaction of the seminal coagulum |
| Concentration in semen | Extremely high: 200,000 – 5,500,000 ng/mL |
| Production | Independent of spermatogenesis — secreted into seminal plasma regardless of sperm presence |
Crucially: PSA is produced by the prostate gland and secreted into seminal fluid regardless of whether the man produces sperm. A vasectomized, oligospermic, or aspermiac male can still produce normal amounts of PSA-containing seminal fluid.
Why Antigen Tests Are Specifically Needed in Aspermia
In a person with aspermia, the usual sequence of events during ejaculation (muscle contractions, orgasm) may occur — but no visible fluid is discharged. However:
- Traces of prostatic secretion may still be deposited on surfaces, clothing, or the victim's body, even without a visible ejaculate.
- These traces contain no sperm → microscopy-based tests are negative and useless.
- But they still contain PSA/P30 → antigen immunoassay tests will be positive.
This means antigen testing is the only reliable method to confirm a seminal stain in aspermia cases.
How the Test Works (ABAcard / Immunochromatographic Method)
The P30/PSA antigen test (e.g., ABAcard® p30) uses a lateral-flow immunochromatographic sandwich assay:
- Stain extract is applied to a porous membrane with a monoclonal anti-PSA antibody linked to a dye.
- If PSA is present → an antigen–antibody complex forms.
- This complex migrates along the membrane to a test region containing a second immobilized anti-PSA antibody.
- An antibody–antigen–antibody "sandwich" forms → a colored line confirms presence of semen.
Sensitivity is comparable to ELISA and can detect PSA in stains stored at room temperature for up to 30 years.
Other Antigen/Molecular Markers Used
| Marker | Notes |
|---|---|
| PSA / P30 | Most widely used; produced by prostate independently of sperm |
| Semenogelin | Seminal vesicle-specific protein; targeted by RSID™-Semen test; highly specific to seminal fluid |
| Human Seminal Vesicle-Specific Antigen (HSV) | Another prostate/seminal vesicle marker used as confirmatory |
Summary
In aspermia, sperm-based microscopy cannot identify seminal stains. Antigen tests (PSA/P30) are used because PSA is produced by the prostate independently of sperm production, is present in extremely high concentrations in seminal fluid (even trace amounts), and its detection is strong forensic evidence of a seminal stain — regardless of the donor's sperm status.
This principle extends equally to azoospermia, vasectomy, retrograde ejaculation, and oligospermia — all conditions where sperm-based testing would miss a genuine seminal deposit.
In aspermia there's nopres
Your message seems to have been cut off — "In aspermia there's nopres..."
Could you complete your question? For example, were you going to say:
- "...no presence of semen at all, so how can PSA be detected?"
- "...no prostatic secretion?"
- something else?
In aspermia there's no sperm in ejaculate?
No — this is an important distinction:
Aspermia vs. Azoospermia
| Term | Definition |
|---|---|
| Aspermia | No ejaculate fluid at all — the man experiences orgasm but nothing is discharged from the urethra ("dry ejaculate") |
| Azoospermia | Ejaculate fluid is present, but it contains no sperm cells |
| Oligospermia | Ejaculate fluid is present, but sperm count is abnormally low |
So in aspermia, the problem is the absence of the fluid itself, not just the absence of sperm. There is no semen, no sperm, and no visible ejaculate.
This is why aspermia is the most challenging scenario in forensic seminal stain analysis — because:
- There are no sperm → microscopy fails
- There is no bulk seminal fluid → even chemical tests like acid phosphatase may be negative or weakly positive
However, even in aspermia, microscopic traces of prostatic secretion can still be deposited (e.g., pre-ejaculatory fluid, urethral residue), and these traces contain PSA/P30 — which is why sensitive immunoassay antigen tests can still yield a positive result on the stain.
In contrast, azoospermia has plenty of seminal fluid (and thus plenty of PSA) — just no sperm — making antigen testing straightforward in that case.
Why is Mab4eb used in antigen tests?
Searching the Web
Mab4E4 monoclonal antibody antigen test seminal stain forensic semen identification
Finding Sources
Searching the Web
MHS-5 MAb4E4 monoclonal antibody semenogelin seminal vesicle specific antigen forensic
You're likely referring to MHS-5 (sometimes written as MAb MHS-5), which is the key monoclonal antibody used in seminal stain antigen testing. Here's a full explanation:
What is MHS-5?
MHS-5 is a monoclonal antibody (MAb) raised against a seminal vesicle-specific antigen (SVSA) — a protein produced exclusively by the epithelial cells of the human seminal vesicles.
The antigen it recognizes is now understood to be semenogelin (and related seminal vesicle-specific peptides), which are the primary structural proteins of the seminal coagulum.
Why MHS-5 Is Used in Seminal Stain Detection
1. Seminal Vesicle Exclusivity
The MHS-5 antigen is found only in human seminal vesicle tissue — it is absent from:
- All other human organs and body fluids
- Semen of common domestic animals (dogs, cats, pigs)
- Even the semen of monkeys (though it IS present in great apes — chimpanzee, gorilla, orangutan, reflecting evolutionary closeness)
This extreme specificity means a positive MHS-5 result is definitive evidence of human seminal fluid.
2. Independent of Sperm Production
Crucially for aspermia/azoospermia cases:
- The MHS-5 antigen is a secretory product of the seminal vesicle epithelium, not of the testes or sperm cells
- Epididymal sperm (obtained before mixing with seminal vesicle fluid) lack the MHS-5 antigen
- After ejaculation, the antigen coats the surface of sperm (it is a "sperm-coating antigen")
- Therefore, in vasectomized, azoospermic, or aspermiac males, the seminal vesicles still produce and secrete the MHS-5 antigen normally — making the test positive even with no sperm
This was directly confirmed: MHS-5 ELISA was validated on semen from 421 vasectomized and normal males — the antigen was conserved in all samples (Herr & Woodward, 1986, Biol. Reprod.).
3. High Sensitivity
The MHS-5-based ELISA is sensitive to as little as 1 ng of seminal protein — making it capable of detecting trace or degraded stains.
4. Persistence in Forensic Samples
MHS-5 has been shown to yield positive results in:
- Sexual assault evidence samples stored up to 6 months
- Vaginal swabs up to 47 hours after the alleged assault
- Even cases where microscopy found no spermatozoa
How It Is Used in Practice
The MHS-5 antibody is the basis of the SEMA kit (ELISA format). The assay works as a standard immunoassay:
- Stain extract is incubated with the biotinylated MHS-5 monoclonal antibody
- If the seminal vesicle antigen is present → antibody–antigen complex forms
- The complex is captured and detected via colorimetric signal (ELISA) or lateral-flow membrane strip
MHS-5 vs. PSA (P30) — Key Comparison
| Feature | MHS-5 (SVSA/Semenogelin) | PSA / P30 |
|---|---|---|
| Source | Seminal vesicle epithelium | Prostatic epithelium |
| Specificity | Highly specific to human semen | Found in small amounts in breast milk, female urine |
| Utility in aspermia | Yes — vesicle secretion present | Yes — prostatic secretion present |
| Cross-reactivity | None in human fluids | Rare cross-reactivity with some female fluids |
Summary
MHS-5 is used because it targets an antigen produced exclusively by the human seminal vesicle, completely independently of sperm. In aspermia (and azoospermia/vasectomy), where no sperm are present, the seminal vesicles still secrete this antigen — so MHS-5-based testing can confirm a seminal stain even when microscopy is entirely negative.
This is a shared conversation. Sign in to Orris to start your own chat.